Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis

Keio Journal of Medicine

Volumn 52, Issue 3, 2003, Pages 147-150

  Iwamoto, Jun ^a   Takeda, Tsuyoshi ^a   Ichimura, Shoichi ^b  

^a KEIO UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone formation; Bone resorption; Postmenopausal osteoporosis; Vitamin D3; Vitamin K2

Indexed keywords

4 CARBOXYGLUTAMIC ACID; ALFACALCIDOL; CALCIFEDIOL; CALCITRIOL; CARBOXYLASE; COLECALCIFEROL DERIVATIVE; ESTROGEN; FARNOQUINONE; GLUTAMIC ACID; HYDROXYAPATITE; MENATETRENONE; OSTEOCALCIN; PROCOLLAGEN C PROTEINASE; PYRIDINOLINE; COLECALCIFEROL;

BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; BONE TURNOVER; CARBOXYLATION; DIETARY INTAKE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FRAGILITY FRACTURE; HUMAN; LUMBAR SPINE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OUTCOMES RESEARCH; PERIOSTEUM; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN SECRETION; REVIEW; TRABECULAR BONE; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANIMAL; BONE; CLINICAL TRIAL; FEMALE; MIDDLE AGED; OSTEOPOROSIS; PATHOLOGY; POSTMENOPAUSE; RAT;

ANIMALS; BONE AND BONES; BONE RESORPTION; CHOLECALCIFEROL; CLINICAL TRIALS; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; POSTMENOPAUSE; RATS; VITAMIN K 2;

EID: 0141867808     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.52.147     Document Type: Review

References (33)

1. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994; 54: 370-376
2. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ: Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994; 308: 1081-1082
3. Tanizawa T, Imura K, Ishii Y, Nishida S, Takano Y, Mashiba T, Endo N, Takahashi HE: Treatment with active vitamin D metabolites and concurrent treatments in the prevention of hip fractures: a retrospective study. Osteoporos Int 1999; 9: 163-170
4. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000; 15: 515-521
5. Szulc P, Chapuy MC, Meunier PJ, Delmas PD: Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91: 1769-1774
6. Weber P: Management of osteoporosis: is there a role for vitamin K? Int J Vitam Nutr Res 1997; 67: 350-356
7. Shearer MJ: Vitamin K. Lancet 1995; 345: 229-234
8. Vermeer C, Jie KS, Knapen MH: Role of vitamin K in bone metabolism. Annu Rev Nutr 1995; 15: 1-22
9. 2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 1997; 12: 431-438
10. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, et al: Increased bone formation in osteocalcin-deficient mice. Nature 1996; 382: 448-452
11. Hauschka PV, Carr SA: Calcium-dependent α-helical structure in osteocalcin. Biochemistry 1982; 21: 2538-2547
12. 2 (menaquinone 4). J Clin Exp Med 1992; 161: 439-440 (in Japanese)
13. 2 on bone loss in ovariectomized rats. Nippon Yakurigaku Zasshi 1994; 104: 101-109 (in Japanese)
14. Orimo H, Fujita T, Onomura T, Inoue T, Kushida K, Shiraki M: Clinical evaluation of Ea-0167 (menatetrenone) in the treatment of osteoporosis: phase III double-blind multicenter comparative study with alfacalcidol. Clin Eval 1992; 20: 45-100 (in Japanese)
15. Shiraishi A, Takeda S, Masaki T, Higuchi Y, Uchiyama Y, Kubodera N, Sato K, Ikeda K, Nakamura T, Matsumoto T, et al: Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Miner Res 2000; 15: 770-779
16. Shiraishi A, Higashi S, Masaki T, Saito M, Ito M, Ikeda S, Nakamura T: A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Calcif Tissue Int 2002; 71: 69-79
17. 2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study. Jpn J Pharmacol 1999; 80: 67-74
18. 2 on three-dimensional trabecular microarchitecture in ovariectomized rats. J Bone Miner Res 2000; 15: 1810-1817
19. Binkley N, Krueger D, Engelke J, Crenshaw T, Suttie J: Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats. Bone 2002; 30: 897-900
20. 2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats. J Bone Miner Res 2003; 18: 776-783
21. Sairanen S, Karkkainen M, Tahtela R, Laitinen K, Makela P, Lamberg-Allardt C, Valimaki MJ: Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years. Calcif Tissue Int 2000; 67: 122-127
22. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T: A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001; 86: 1212-1221
23. 3 and estrogen-progestin therapy. Maturitas 1999; 31: 161-164
24. Plantalech L, Guillaumont M, Vergnaud P, Leclercq M, Delmas PD: Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women. J Bone Miner Res 1991; 6: 1211-1216
25. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD: Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997; 82: 719-724
26. Matsunaga S, Ito H, Sakou T: The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int 1999; 65: 285-289
27. 3 on bone loss in ovariectomized rats. Nippon Yakurigaku Zasshi 2001; 118: 231-240 (in Japanese)
28. 3 on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas 2002; 41: 211-221
29. 2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J Orthop Sci 2000; 5: 546-551
30. 2. Clinical Calcium 2002; 12: 950-954 (in Japanese)
31. Orimo H, Sugioka Y, Fukunaga M, Muto Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Ikai T, Oh-hashi Y: Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 1998; 16: 139-150
32. Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, et al: Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 2001; 19: 331-337
33. Keaveny TM, Yeh OC: Architecture and trabecular bone: toward an improved understanding of the biomechanical effects of age, sex, and osteoporosis. J Musculoskel Neuron Interact 2002; 2: 205-208